Our study found for the first time that some antihypertensive drugs with central action (clonidine), α and β blockers (carvedilol and labetalol), renin inhibitors (aliskiren), and vasodilators (hydralazine and nitroglycerin) were associated with increased risk of hyperuricaemia, gout or related AEs. The gene discussed is REN; the disease is gout.